FR2218091B1 - - Google Patents

Info

Publication number
FR2218091B1
FR2218091B1 FR7305741A FR7305741A FR2218091B1 FR 2218091 B1 FR2218091 B1 FR 2218091B1 FR 7305741 A FR7305741 A FR 7305741A FR 7305741 A FR7305741 A FR 7305741A FR 2218091 B1 FR2218091 B1 FR 2218091B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7305741A
Other languages
French (fr)
Other versions
FR2218091A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR7305741A priority Critical patent/FR2218091B1/fr
Priority to BE140133A priority patent/BE810112A/en
Priority to ZA00740655A priority patent/ZA74655B/en
Priority to DE2404983A priority patent/DE2404983A1/en
Priority to IL44135A priority patent/IL44135A/en
Priority to MC1090A priority patent/MC1000A1/en
Priority to NL7401983A priority patent/NL7401983A/xx
Priority to ES0423245A priority patent/ES423245A1/en
Priority to LU69412A priority patent/LU69412A1/xx
Priority to AT129774A priority patent/AT339473B/en
Priority to AU65758/74A priority patent/AU6575874A/en
Priority to OA55124A priority patent/OA04602A/en
Priority to GB748274A priority patent/GB1465553A/en
Publication of FR2218091A1 publication Critical patent/FR2218091A1/fr
Application granted granted Critical
Publication of FR2218091B1 publication Critical patent/FR2218091B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32411—Hepatovirus, i.e. hepatitis A virus
    • C12N2770/32432—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR7305741A 1973-02-19 1973-02-19 Expired FR2218091B1 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
FR7305741A FR2218091B1 (en) 1973-02-19 1973-02-19
BE140133A BE810112A (en) 1973-02-19 1974-01-24 ANTINEOPLASIC DRUG
ZA00740655A ZA74655B (en) 1973-02-19 1974-01-31 Medicament for use in the treatment of cancer
DE2404983A DE2404983A1 (en) 1973-02-19 1974-02-01 AGAINST CANCER MEDICINAL PRODUCTS AND THE METHOD FOR MANUFACTURING IT
IL44135A IL44135A (en) 1973-02-19 1974-02-04 Anticancer medicament containing human serum
MC1090A MC1000A1 (en) 1973-02-19 1974-02-08 Process for the preparation of an antineoplastic drug
NL7401983A NL7401983A (en) 1973-02-19 1974-02-13
ES0423245A ES423245A1 (en) 1973-02-19 1974-02-14 Procedure for obtaining an anticancerous procedure. (Machine-translation by Google Translate, not legally binding)
LU69412A LU69412A1 (en) 1973-02-19 1974-02-18
AT129774A AT339473B (en) 1973-02-19 1974-02-18 PROCESS FOR OBTAINING A NEW REMEDY FOR THE THERAPEUTIC TREATMENT OF CANCER DISEASES AND FOR PROPHYLAXIS AGAINST SUCH DISEASES
AU65758/74A AU6575874A (en) 1973-02-19 1974-02-19 Anticancer medicine
OA55124A OA04602A (en) 1973-02-19 1974-02-19 A method of manufacturing an antineoplastic drug.
GB748274A GB1465553A (en) 1973-02-19 1974-02-19 Anticancer medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7305741A FR2218091B1 (en) 1973-02-19 1973-02-19

Publications (2)

Publication Number Publication Date
FR2218091A1 FR2218091A1 (en) 1974-09-13
FR2218091B1 true FR2218091B1 (en) 1976-07-02

Family

ID=9115016

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7305741A Expired FR2218091B1 (en) 1973-02-19 1973-02-19

Country Status (13)

Country Link
AT (1) AT339473B (en)
AU (1) AU6575874A (en)
BE (1) BE810112A (en)
DE (1) DE2404983A1 (en)
ES (1) ES423245A1 (en)
FR (1) FR2218091B1 (en)
GB (1) GB1465553A (en)
IL (1) IL44135A (en)
LU (1) LU69412A1 (en)
MC (1) MC1000A1 (en)
NL (1) NL7401983A (en)
OA (1) OA04602A (en)
ZA (1) ZA74655B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2685870B1 (en) * 1992-01-03 1995-07-07 Soussan Andre ANTI-CANCER DRUG.

Also Published As

Publication number Publication date
ZA74655B (en) 1975-09-24
IL44135A0 (en) 1974-06-30
ES423245A1 (en) 1976-05-01
LU69412A1 (en) 1974-05-29
BE810112A (en) 1974-05-16
ATA129774A (en) 1977-02-15
OA04602A (en) 1980-06-30
GB1465553A (en) 1977-02-23
FR2218091A1 (en) 1974-09-13
AT339473B (en) 1977-10-25
NL7401983A (en) 1974-08-21
MC1000A1 (en) 1974-10-18
IL44135A (en) 1976-12-31
AU6575874A (en) 1975-08-21
DE2404983A1 (en) 1974-10-17

Similar Documents

Publication Publication Date Title
AR201758A1 (en)
AU465372B2 (en)
AR201235Q (en)
AR201231Q (en)
AU474593B2 (en)
AU474511B2 (en)
AU465453B2 (en)
AU471343B2 (en)
AU465434B2 (en)
AU450229B2 (en)
AR201229Q (en)
AU466283B2 (en)
AU472848B2 (en)
AR199451A1 (en)
FR2218091B1 (en)
AR200885A1 (en)
AR195311A1 (en)
AR201432A1 (en)
AR193950A1 (en)
AR210729A1 (en)
AU471461B2 (en)
AU447540B2 (en)
AR200256A1 (en)
AU461342B2 (en)
AR197627A1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse